Star Combo Pharma Limited (ASX:S66)

Star Combo Pharma Revenue

In the fiscal year ending June 30, 2026, Star Combo Pharma had annual revenue of 23.57M AUD, down -15.24%. Star Combo Pharma had revenue of 11.64M in the half year ending June 30, 2026, a decrease of -15.55%.

• Revenue: 23.57M
• Revenue Growth: -15.24%
• P/S Ratio: 0.80
• Revenue / Employee: 785.77K
• Employees: 30
• Market Cap: 18.91M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	23.57M	-4.24M	-15.24%
Jun 30, 2025	27.81M	1.79M	6.89%
Jun 30, 2024	26.02M	1.32M	5.34%
Jun 30, 2023	24.70M	1.74M	7.57%
Jun 30, 2022	22.96M	-4.01M	-14.86%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 3, 2026

Data Sources Report a data error